|
- 2017
Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practiceDOI: 10.1038/s41533-017-0040-z Abstract: Number of patients by therapy combination at COPD diagnosis (overall cohort). COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids, LABA long-acting beta-agonists, LAMA long-acting muscarinic antagonists, SABA short-acting beta-agonists, SAMA short-acting muscarinic antagonist
|